Article Information
History
- January 9, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Hiroaki Nagamine1,3,¶,
- Masakazu Yashiro2,*,¶,
- Megumi Mizutani3,
- Akira Sugimoto3,
- Yoshiya Matsumoto3,
- Yoko Tani4,
- Kenji Sawa4,
- Hiroyasu Kaneda4,
- Kazuhiro Yamada3,
- Tetsuya Watanabe3,
- Kazuhisa Asai3,
- Satoshi Suzuki5,& and
- Tomoya Kawaguchi3,4
- 1Department of Respiratory Medicine, Osaka City University, Graduate School of Medicine, Osaka, Japan
- 2Molecular Oncology and Therapeutics, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan
- 3Department of Respiratory Medicine, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan
- 4Department of Clinical Oncology, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan
- 5Department of Thoracic Surgery, Osaka Metropolitan University, Graduate School of Medicine, Osaka, Japan
- ↵*Corresponding Author: Masakazu Yashiro ORCID: Masakazu Yashiro (https://orcid.org/0000-0001-5743-7228) Email: i21496f{at}omu.ac.jp (MY)
Posted January 09, 2024.
Insulin-like Growth Factor 1 Receptor Expression Correlates with Programmed Death Ligand 1 Expression and Poor Survival in Non-small Cell Lung Cancer
